<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">4943</id>
  <title>T3D4888</title>
  <common-name>Apigenin</common-name>
  <description>Apigenin is a plant-derived flavonoid that has significant promise as a skin cancer chemopreventive agent. Apigenin inhibits the expression of involucrin (hINV), a marker of keratinocyte differentiation, is increased by differentiating agents via a protein kinase Cdelta (PKCdelta), Ras, MEKK1, MEK3 cascade that increases AP1 factor level and AP1 factor binding to DNA elements in the hINV promoter. Apigenin suppresses the 12-O-tetradeconylphorbol-13-acetate-dependent increase in AP1 factor expression and binding to the hINV promoter and the increase in hINV promoter activity. Apigenin also inhibits the increase in promoter activity observed following overexpression of PKCdelta, constitutively active Ras, or MEKK1. The suppression of PKCdelta activity is associated with reduced phosphorylation of PKCdelta-Y311. Activation of hINV promoter activity by the green tea polyphenol, (-)-epigellocathecin-3-gallate, is also inhibited by apigenin, suggesting that the two chemopreventive agents can produce opposing actions in keratinocytes. (A7924). Apigenin, a flavone abundantly found in fruits and vegetables, exhibits antiproliferative, anti-inflammatory, and antimetastatic activities through poorly defined mechanisms. This flavonoid provides selective activity to promote caspase-dependent-apoptosis of leukemia cells and uncover an essential role of PKCdelta during the induction of apoptosis by apigenin. (A7925). Apigenin markedly induces the expression of death receptor 5 (DR5) and synergistically acts with exogenous soluble recombinant human tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to induce apoptosis in malignant tumor cells. On the other hand, apigenin-mediated induction of DR5 expression is not observed in normal human peripheral blood mononuclear cells. Moreover, apigenin does not sensitize normal human peripheral blood mononuclear cells to TRAIL-induced apoptosis. (A7926).</description>
  <cas>520-36-5</cas>
  <pubchem-id>5280443</pubchem-id>
  <chemical-formula>C15H10O5</chemical-formula>
  <weight nil="true"/>
  <appearance>White powder.</appearance>
  <melting-point>347.5 °C</melting-point>
  <boiling-point></boiling-point>
  <density nil="true"/>
  <solubility></solubility>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure></route-of-exposure>
  <target nil="true"/>
  <mechanism-of-toxicity></mechanism-of-toxicity>
  <metabolism></metabolism>
  <toxicity></toxicity>
  <lethaldose></lethaldose>
  <carcinogenicity>No indication of carcinogenicity to humans (not listed by IARC).</carcinogenicity>
  <use-source></use-source>
  <min-risk-level></min-risk-level>
  <health-effects></health-effects>
  <symptoms></symptoms>
  <treatment></treatment>
  <created-at type="dateTime">2014-09-11T05:20:57Z</created-at>
  <updated-at type="dateTime">2026-03-27T01:49:21Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia>http://en.wikipedia.org/wiki/Apigenin</wikipedia>
  <uniprot-id></uniprot-id>
  <kegg-compound-id>C01477</kegg-compound-id>
  <omim-id></omim-id>
  <chebi-id>18388</chebi-id>
  <biocyc-id>CPD-431</biocyc-id>
  <ctd-id>D047310</ctd-id>
  <stitch-id></stitch-id>
  <drugbank-id>DB07352</drugbank-id>
  <pdb-id>AGI</pdb-id>
  <actor-id></actor-id>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>OC1=CC=C(C=C1)C1=CC(=O)C2=C(O)C=C(O)C=C2O1</moldb-smiles>
  <moldb-formula>C15H10O5</moldb-formula>
  <moldb-inchi>InChI=1S/C15H10O5/c16-9-3-1-8(2-4-9)13-7-12(19)15-11(18)5-10(17)6-14(15)20-13/h1-7,16-18H</moldb-inchi>
  <moldb-inchikey>KZNIFHPLKGYRTM-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal">270.2369</moldb-average-mass>
  <moldb-mono-mass type="decimal">270.05282343</moldb-mono-mass>
  <origin>Exogenous</origin>
  <state>Solid</state>
  <logp>3.02</logp>
  <hmdb-id>HMDB02124</hmdb-id>
  <chembl-id>CHEMBL28</chembl-id>
  <chemspider-id>4444100</chemspider-id>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference>Chen, Xin; Li, Ping.  Processes for the preparation of apigenin from naringin via rhoifolin or naringenin intermediate.    Faming Zhuanli Shenqing Gongkai Shuomingshu  (2005),     9 pp</synthesis-reference>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM003844</chemdb-id>
  <dsstox-id>DTXSID6022391</dsstox-id>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id>NS00007770</susdat-id>
  <iupac>5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one</iupac>
</compound>
